Kairos Pharma, Ltd. · AMEX:KAPA
Armistice Capital, LLC reported a 9.99% stake in Kairos Pharma, Ltd. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Armistice Capital, LLC reported a 9.99% stake in Kairos Pharma, Ltd., 1,696,924 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 1,696,924
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 1,696,924 |
| Steven Boyd | 9.99% | 1,696,924 |